[Column] Contributing to Efficient Active Pharmaceutical Ingredient Process Development by Utilizing Asymmetric Synthesis Technology
Development of scalable active pharmaceutical ingredient processes! We are expanding a comprehensive CDMO business.
In recent years, there have been cases where new compounds with extremely complex chemical structures or compounds with unknown physical property information are considered as candidates for new drugs, and Spira Pharma has seen an increase in requests for the manufacturing development and GMP production of such compounds. In response to the demand for prioritizing development speed, our company is taking on the challenge of process development for manufacturing methods that progress to scale-up, which I believe reflects the high expectations placed on our technical capabilities. How are we tackling the development of manufacturing methods for highly challenging compounds within a strict timeline? We spoke with the chief researcher of the Pharmaceutical Research Headquarters, incorporating examples. As experts in CMC research, our company provides comprehensive support for solving customer challenges, from early-stage R&D to clinical trial drug manufacturing, analysis, application support, and consulting. *For more details on the column, please refer to the related link. For further inquiries, please feel free to contact us.*
Inquire About This Product
basic information
*You can view the detailed content of the column through the related link. For more information, please feel free to contact us.*
Price range
Delivery Time
Applications/Examples of results
*You can view the detailed content of the column through the related link. For more information, please feel free to contact us.*
catalog（1）
Download All Catalogs
Company information
Our company is a pharmaceutical CMC research and development contract company that spun out from the CMC research division of Takeda Pharmaceutical Company Limited in July 2017. We support excellent pharmaceutical development as experts in CMC research. Our research team consists of experts with extensive experience and achievements in process chemistry, formulation research and development, and analytical testing development related to CMC research. We provide high-level services and solutions tailored to our customers' needs across each process from the early stages of pharmaceutical development to application, while flexibly collaborating. We have established a collaborative system with partner companies, enabling us to offer a one-stop service. Please utilize us as a platform for your pharmaceutical development.
